He aha ia he kolamu a he aha ka hana me kona kiʻekiʻe kiʻekiʻe?

He aha ka cholesterol? ʻO Cholesterol he waiwai kūʻokoʻa e pili ana i ka hui o nā alcohols. ʻO ka pūhui he waiʻona polyophclic lipophilic maʻamau.

Ma nā biochemistry, he mea maʻamau ka kāhea i kēia mea kanu mea, e like me ka papa i ʻae ʻia, kolamu. ʻO kēia māhele kekahi o nā mea pono e pili ana i ka hoʻokō ʻana i nā hapanui e pili ana.

ʻO ka nui o ke kolamu e pono ai no ka hana maʻamau o nā kino āpau i hana ʻia i loko o nā ate a me kekahi mau mea kino ʻē aʻe. ʻO kahi ʻāpana liʻiliʻi o kēia ʻano mea i komo i ke kino o ka ʻāpana o ka meaʻai.

ʻO ka palupalu lipophilic e hele mai ana mai waho aku e kapa ʻia ka endogenous, synthesized ma ka ate a me kekahi mau mea ʻē aʻe, ua kapa ʻia he exogenous.

Ke kūʻokoʻa kū pono ke kino o ke kanaka e pili ana i ka 80% o ka pia lipophilic e pono ai no ia, a he 20% wale nō ka hele ʻana mai ka kaona mai me ka meaʻai. Hoʻopili kūleʻa ka mea hoʻoneʻe i ka wai i loko o ka wai, akā hoʻomau maikaʻi ʻia i loko o nā momona.

He hana koiola a me ka biosynthesis

He mea paʻakikī ka hoʻonāukiuki a ka hana o kēia ʻoihana hoʻohui bioactive; e pono ai no ka hana maʻamau a me ke hoʻoponopono ʻana i ke ola.

ʻO Cholesterol kekahi ʻāpana o ka membrane cell, hāʻawi iā ia i kekahi ikaika a me ka kūpaʻa ma muli o ka hoʻopiʻi ʻana o ka hōʻulu ʻana o nā mololi phospholipid. I kēia hihia, hoʻokō kēia ʻāpana i ke kuleana o ka stabilizer o ka membrane plasma o ka pā.

Hāʻawi ke kolesterol i kahi kaulahao o nā ʻōhua biosynthesis e hopena i ka hoʻokumu ʻana o nā hormones sex steroid, e like me testosterone a me corticosteroids.

Ma kahi o kēia mau hana, hāʻawi ia i ka synthesis o nā huaora o ka pūʻulu D.

Ma luna o kēia, ʻaʻole pau nā hana o ka wai lālani lipophilic.

1. Hāʻawi i ka permeability koho o nā membrane plasma o nā pūpū;
2. pale aku i nā wahi ʻulaʻula mai nā hopena maikaʻi ʻole o nā toxins hemolytic;
3. komo i ka hāʻawi 'ana i ka mākeke a me nā mea kanu, komo i ke kahe ʻana o kekahi mau palekala a me nā mea ʻalae mai nā pūpū a nā ʻūpā o nā ʻōpū o ka wai ʻole;
4. ka hana i ka hana o ke aʻa o ke ohe i komo i loko o ka hana ʻana.

ʻO ka biosynthesis Cholesterol kahi pae mika o nā hōʻike biochemical e hōʻoia i ka hoʻokumu ʻana o kahi waiola kūlohelohe o kahi ʻano steroid.

Hoʻopili ʻia nā pane ʻana a pau i kahi ʻano reticulum endoplasmic maemae. Hāʻawi kēia kaʻina kumu i ka hoʻokumu houʻana o nā kumuwaiwai olakino hou o ke ʻano o ke ʻano.

ʻO nā papa mua o ka biosynthesis ka mea maʻamau me ka synthes reaksyon o nā isoprenoids ʻē aʻe.

Hiki ke hoʻokaʻawale i nā ʻāpana āpau āpau o kēia ʻāpana i nā ʻano nui:

• Loaʻa i kahi mevalonate ʻelima mauʻai mai ʻekolu molekika o ka acetate ikaika.
• ʻO ka hoʻololi ʻana o ka mevalonate i ka isoprenoid ikaika - isopentenylpyophosphate.
• ʻO ka syntess o nā molekika ʻeono o ka isopentenyl pyophosphate isoprenoid squalene ka mea i kanakolu ʻia o nā momoma karbon he kanakolu.
• ʻO ke kāpili o kahi hoʻolālā cyclic. I loko o kēia hana, loaʻa ka squalene i kahi hoʻolālā cyclic a lilo i lanosterol.

I ka hana hope o ka biosynthesis, ua hoʻohuli ʻia ka lanosterol i ka cholesterol.

I loko o nā kānaka, ʻo ka cholesterol manuahi he ʻāpana o nā paʻakikī i loaʻa i ka molika molika a me nā protein transporter. Ua kapa ʻia kēia mau mea paʻakikī i ka lipoproteins.

ʻO nā ʻano nui o nā lipoproteins

Ma muli o ka ʻike ʻole o ka cholesterol i ka wai i loko o ka wai, e kahe ʻia i nā ʻili me he ʻāpana o nā pūhui koʻikoʻi me nā ʻōnaehana lawe lima o kēia ʻāpana.

Ua kapa ʻia kēia mau mea paʻakikī i ka lipoproteins.

Ua hoʻokaʻawale ʻia nā lipoproteins i ʻole a hoʻokaʻawale i ka wai a me ka sololuble, kahi ʻano.

ʻO nā lipoproteins Insoluble he ʻāpana o nā membrane cell a me ka wahī myelin o nā kinipū nerve.

ʻO nā lipoproteins manuahi he māhele ia o ka plasma koko, ʻo ia kahi o nā pūhui e hōʻoia ai i ka lawe ʻana i ka kolamu.

Hoʻokaʻawale ʻia ka laulā o ka lipoproteins i kekahi mau pūʻulu e like me ke ʻano o nā lipids i kā lākou hui. ʻOi aku ka kiʻekiʻe o ka lipid, e hoʻohaʻahaʻa i ka haʻahaʻa o ka pūlima paʻakikī

I ke kāne ua nui nā ʻano ʻano paʻakikī o kēia.

ʻO ka mea nui i waena o kēia mau paʻakikī.

1. Nā lipoproteins kūwaho kiʻekiʻe - HDL. He nui ka paʻakikī a 8 i ka 11 nm. Hāʻawi kēia ʻano ʻano paʻakikī i ka lawe ʻana i ka kolamu mai nā kiko peripheral i nā ʻāpana o nā ate.
2. He lipoproteins haʻahaʻa haʻahaʻa - LDL, he nui o 18 a 26 nm. Hāʻawi ka pūhui paʻakikī i ka lawe ʻana i ka kolamu, triacylglycerides a me nā phospholipids mai nā palekima o nā palu i nā peka o nā koina peripheral.
3. ʻO ka lipoproteins Intermediate density - LPP, he nui ka 25 a 36 nm a lawe aku i ka waiʻona lipophilic a me ka phospholipids mai nā palekū aʻai i nā cell kiko i ka periphery.
4. ʻO nā lipoproteins haʻahaʻa haʻahaʻa - nā VLDLP, ua nui ka nui o 30 a 80 mau nm, ka lawe ʻana i ka kolesterol a me ka tracylglycerides mai ka palapaleka i nā ʻiʻo peripheral.
5. ʻO nā Chylomicrons nā mea lawe nui loa, ʻo ko lākou nui ka mai 75 a 1200 nm. ʻO kēia mau pūhui e hōʻoia i ka lawe ʻana i nā kolamu a me nā momona momona mai ka meaʻai mai nā ʻōpū i nā kiko peripheral a i nā pūpuna ate.

ʻO ka heleʻana o kahi pilina paʻa ʻole ma waena o nā protein a me nā lipids i ka hoʻonohonoho ʻana o nā mea paʻakikī. Hāʻawi ka pilina o ia palapala a me ka hoʻōla o ka lipid free a me kahi hoʻololi i nā ʻano o nā lipoproteins.

ʻO ka maʻamau a me nā kaʻeʻe ʻana i ka ʻike kolamu

No ka nohona maʻamau, pono i ka pae o ka waiʻona lipophilic i loko o ke koko koko e holo like i kekahi nui.

No ka huakini piha, pono ka ʻike kino o ke koko mai ka 3.0 a hiki i 6.0 mmol / L.

ʻO ka māka ma ka pae kūpono ma lalo o 5.2 mmol / l, inā he mau hōʻailona ka palena o 5.2 a 6.2 mmol / l, a laila ʻike ʻia ke alapine, kūpono, kahi hōʻailona ma luna o 6.2 mmol / l i kahi kiʻekiʻe.

No nā ʻike o LDL i ka plasma, ua ʻae ʻia kēia ʻano makahiki e like me kēia:

• ma lalo o 1,8 mmol / l - kūpono loa no ka poʻe me ka hopena kiʻekiʻe o ka hoʻomohala ʻana i ka maʻi cardiovascular;
• ma lalo o 2.6 mmol / l - ka waiwai maikaʻi loa no ka poʻe e hōʻailona ana i kahi predisposition i ka loaʻa ʻana o ka maʻi cardiovascular;
• 2.6-3.3 mmol / l - ka waiwai maikaʻi loa;
• 3.4-4.1 mmol / l - ka hōʻailona hiki i ke kuhikuhi;
• 4.1-4.9 mmol / L - i manaʻo ʻia he waiwai nui;
• kahi waiwai ma luna o 4.9 mmol / L - kahi kiʻekiʻe kiʻekiʻe o ka LDL i ka plasma.

He kiʻekiʻe ka pae o HDL i nā kāne a me nā wahine:

ʻO kahi hōʻailona hōʻike maikaʻi loa o ka loaʻa ʻana o HDL i plasma.

1. No nā kāne - emi iho ma lalo o 1 mmol / l.
2. No nā wahine, emi iho ma lalo o 1,3 mol / L.

Hoʻoholo ʻia kēia mau mea kūpono i ka lāʻau lapaʻau:

• no nā kāne - 1.0-1.3 mmol / l;
• no nā wahine - 1.3-1.5 mmol / l.

1.6 mmol / L i nā wahine a me nā kāne i manaʻo ʻia he mau hōʻailona maikaʻi loa o ka HDL i ka plasma.

Hoʻokumu ka pae o ka lipids i ka kāne, wahine a me ke ʻano.

E pili ana nā mea hou i ka ʻikepili lipid i nā wahine

1. Ka manawa o ka makahiki. Aia i ka manawa o ka makahiki, hiki i ka parameter ke kikoʻī wahine ke neʻe i hoʻokahi ʻaoʻao a i ʻole kekahi ma kahi o 2-4% o ka awelika. Hoʻomaopopo ka nui o ka ulu i loko o ke kau anuanu. He ʻano maʻamau kēia ʻano kūloko.
2. ʻO ke ʻano o ka pōʻai ʻana ʻo ka kāne. I ka hapa mua o ka hānō menstrual, hiki ke kaʻe ʻana mai ka maʻamau a 10%. Manaʻo ʻia kahi kūlike.
3. ʻO ka wā hānau o ke keiki. Ma mua o ka hāpaiʻana, hiki ke hoʻonui i nā pae lipid e hoʻonui i ka 12-15% o nā ʻike maʻamau.
4. ʻO ka hiki ʻana o nā maʻi hōʻemi ke hoʻemi i ka hoʻōki o ka pehu lipophilic, i hoʻopili ʻia me ka hoʻoulu hou ʻana i nā hua a nā maʻi a me ka ʻai o ka kolamu no ka kūkulu ʻana o nā membrane.

I ka manawa i hiki ai ka wahine i nā makahiki o 40-45 mau makahiki a me ka piha o ka hana keiki ʻana i ka ʻōpū o ka wahine, ʻike ʻia kahi emi o ka nui o ka HDL a me ka piʻi ʻana o LDL.

Loaʻa kahi kūlana like i waena o nā kāne, kahi e hoʻonui ai i ka nui o ka LDL a me ka hoʻohaʻahaʻa o HDL.

ʻO ka ʻokoʻa i loko o ke kino kāne, he piʻi i ka nui o ka cholesterol i mālama ʻia a hiki i 50 mau makahiki. A ma hope o ke hiki ʻana i kēia wā, hoʻomaka ka hōʻailona e hāʻule.

ʻO nā kumu o nā kūlike

Nā hopena hoʻohālikelike o nā hualoaʻa he ʻelua o nā ʻano ʻelua - he ʻokoʻa o ka nui o ka kolamu ma ka plasma koko a me kona hoʻonui. Hoʻo pinepine ʻia ka hoʻohaʻahaʻa ʻana. Hoʻohālikelike i ka hoʻonui.

Noho ka Hyperlipidemia ma ka hapa nui o nā mea pono i ʻike ʻia.

Hiki ke nānā ʻia ke hāʻule ʻana o nā pae lipoprotein i loko o kēia mau kūlana:

• ka pololi a me ke kīpē ʻana o nā momona i ka hoʻopiʻi ʻana i nā pilikia i ka hana o ke kaowai ʻana;
• ka hoʻokau ʻana ʻana o kekahi i kahi paʻa ʻana, a me ka hoʻonaninani ʻana i nā ʻōnaehana hoʻoponopono;
• ka hana hewa ʻana i ka hana hana o ka hana thyroid - hypothyroidism;
• ka hoʻomohala ʻana o ka maʻi thalassemia, megaloblastic anemia a meeloma;
• ka holomua o ka sepsis a me nā maʻi maʻi lohi koʻikoʻi;
• ka loaʻa ʻana o ka haka oncological a i ke kūkulu ʻana i ka cirrhosis terminal o ka ate;
• ka loaʻa ʻana o nā maʻi maʻi pākani a me nā maʻi koʻikoʻi o ka ʻōnaehana hanu.

I kekahi mau kūlana, aia ka emi ʻana o nā pae lipid ma muli o ka lawe ʻana i ka estrogen e like me ka mea he therapeutic agent.

ʻO ka hoʻonui ʻia o nā pae lipid e hele mai i kēia mau hihia:

1. Me ka nui o nā meaʻaiʻai i nā momona holoholona a me nā mea kākoi.
2. Ke hele mai ka anorexia nervosa.
3. I ka wā hānau o ke keiki.
4. I kahi hihia o ka hōʻino maikaʻi ʻana e kekahi kanaka o nā hana maikaʻi e like me ka ulaula, inu inu i ka waiʻona.
5. Hoʻonui a hele pinepine paha i nā kūlana kaumaha.
6. I ka hihia o ka hoʻomohalaʻana o nā pilikia o ka pathological i ka hoʻokōʻana i nā hopena metabol.

ʻO ka hoʻonui ʻia o ka kolamu e alakaʻi i ka hoʻolālā ʻana o ka nui o nā pilikia a me nā maʻi i alakaʻi i kahi hoʻopiʻi ʻana i ke ola o kahi kanaka, ʻo ia nō ka make.

Nā ʻōmohu o kahi kiʻekiʻe o nā lipids i ke kino

ʻAʻole ʻike ʻia ka hoʻomohala ʻana o ka hypercholisterinemia.

ʻO ka nele o nā hōʻailona kikoʻī e pili ana i ka hoʻomohala ʻana i ka hypercholesterolemia me ka hoʻopiʻi nui ʻana i ka maʻi ʻana o nā patology.

Hoʻomaka ka mea maʻi e hoʻopiʻi e pili ana i ke ʻano o kekahi mau hōʻailona ke hele nei ke ʻano o ka lipid ma kahi kiʻekiʻe, ma luna o ka lōʻihi, ke alakaʻi nei i ka hoʻomohala ʻana o nā ʻatikala like ʻole i kahi kanaka e pili ana i ka malfunctions ma lipid metabolism.

ʻO nā mea nui ka cholesterol kiʻekiʻe o ka plasma kiʻekiʻe:

• ua hōʻeha ka mea maʻi ma ka ʻōpū o ka umauma, hōʻeha a hōʻeha paha i ka ʻāʻī puʻuwai, e hōʻemi ʻia e ka nā coronary vessel o ke kaila o ka puni, e hoʻolako pū ai i nā meaʻai a me ka lako o ka oxygen i ka ʻōpū o ka naʻau;
• ma ke alo o ka nui o ka lipids i ka kāne, hoʻomohala a hiki i ka erectile dysfunction e ulu no ka hoʻokumu ʻia ʻana o nā kolamu kolesterol i nā ʻōpala e hānai ai i nā ʻōpū;
• ka hoʻomohala ʻana o ka atherosclerosis a me ka cerebral stroke - nā maʻi a me nā ala e make ai no ke ola kanaka;
• i ka hihia o ka hoʻopōʻino ma muli o ka hoʻolālāʻana o ka hypercholesterolemia o nā paia o nā moku o peripheral o ke kaila o ka lula, ka lawaiʻa ʻana i nā maʻi o ka lalo haʻahaʻa a me ka thrombosis venous me ka holomua o ka thrombophlebitis hiki ke holomua;
• kahi hōʻailona kūlohelohe o ka hiki ʻana o ke kiʻekiʻe o nā lipids hiki ke manaʻo i ke ʻano o ke ʻeha i nā haʻahaʻa haʻahaʻa, kahi ʻike koʻikoʻi i ka hana hoʻomanaʻo a me ke ʻano o nā hōʻeha a me nā hōʻeha o ka naʻau.

Ma kahi o nā hōʻailona i hōʻikeʻia, hōʻike ʻia ka hypercholisterinemia e ka hele ʻana o nā hōʻike o waho.

ʻO kekahi o kēia mau hōʻike he ʻano o ke kanaka maʻi me kahi pāpaʻu lipoid corneal. ʻO kēia hōʻailona ka hiʻohiʻona o ka hypercholisterinemia familial, hōʻike pinepine ʻia i nā mea maʻi i nā makahiki he 50 mau makahiki.

ʻO kekahi hiʻohiʻona hiʻohiʻona o ke ala o nā lipid metabolism ka hoʻokumu ʻana o xanthelasemas. Ke nānā nei kēia mau ʻano me nā nodules liʻiliʻi o ke kala melemele polū. ʻO ka ʻāpana o ka hoʻonohonoho ʻana i kēia mau ʻano he epithelium o nā maka. Hiki nō hoʻi ke hoʻopuka i nā xanthomas, ʻo nā nodules kolesterol e waiho ʻia ma luna o nā tendons.

ʻO kēia mau hōʻike kūʻokoʻa e hōʻike nei i kahi ala nui o nā papa no ke au.

ʻO ka lapaʻau lāʻau lapaʻau o hypercholesterolemia

ʻO ke ʻano no ka mālamaʻana i ka pathology e pili ana i ka hoʻohana ʻana i nā ʻano ʻano like ʻole i ka hoʻomohala ʻana i nā kaʻina hana biochemical e loaʻa i loko o ke kanaka.

Ke hoʻoikaika nei ʻo ia mau ʻano hoʻoikaika kino, hoʻololi i ke ʻano o ka mea maʻi. ʻO ka hana kūpono me ka meaʻai kūikawā, a me ka hopena o nā kaʻina biochemical ma o ka lawe ʻana i nā lāʻau lapaʻau kūikawā e kōkua ana e hoʻoneʻe i nā lipids nui.

Ma hope o ka hoʻokolokolo ʻana i ke kanaka, ʻo ke kauka, inā pono, e kuhikuhi ana i ka hoʻohana ʻana i nā lāʻau lapaʻau kūikawā e pili ana i nā hui like ʻole o nā lāʻau lapaʻau.

ʻO nā ʻano lāʻau maʻamau maʻamau i hoʻohana ʻia i ka mālama ʻana o ka hypercholesterolemia ma:

1. Nā ʻākala Hoʻopili lākou i ka hana a ke ʻano o ka huina e komo ai i ka hana o kolamu. ʻO kēia pūʻulu o nā lāʻau lapaʻau ka mea kaulana loa. Hiki i ke hoʻohana i kēia mau lāʻauʻeneke ke hoʻonui i ka nui o ka kolamu maikaʻi a hoʻēmi i ka nui o nā mea ʻino. Hiki i nā lāʻau o nā huahana hou o kēia hui ke hoʻemi i ka pae o lipids i loko o kahi mea maʻi ma ke koko ma o 60%. Eia kekahi, statins haʻahaʻa triglycerides. ʻO nā ala like loa o kēia hui ʻo Mevacor, Baykol a me Leskol.
2. ʻO nā waikawa Fibric - kōkua e hōʻemi i ka nui o nā triglycerides a kōkua i ka hoʻonuiʻana i ka hoʻihoʻiʻana o ka momona o nā momona momona i loko o nā puʻuwai huna. ʻO kēia pūʻulu o nā lāʻau lapaʻau e komo pū ana me Atromed-S, Tricor a me Lopid.

Eia kekahi, ua hoʻohana nā lāʻau lapaʻau e hāʻawi i ka hopena i ka waikawa bile a hoʻohaʻahaʻa i ka nui o nā synthesis synthesis i nā pūpū mālama. Aia kēia pūʻulu o nā lāʻau lapaʻau iā Colistin a me Questran.

Ma mua o ka hoʻohana ʻana i kekahi o kēia mau kālā, pono ʻoe e kamaʻilio i ke kauka a hana i kahi hoʻokolohua, kahi e komo ai ke ana o ka pae o nā lipids i ka plasma koko.

Ka hoʻohana ʻana i ka meaʻai meaʻai no hypercholisterinemia

ʻO ke kumu nui o ka hoʻohana ʻana i ka meaʻai meaʻai he mea e kūʻē ai i ka hiki ʻana o nā hoʻopiʻi atherosclerotic a me ka wehe ʻana o ka kolamu nui loa. ʻAʻole pono nā meaʻai i ʻai ʻia me ka kolamu. Eia kekahi, ʻo ka hoʻonohonohoʻana o nā huahana i pau nā mea e pono ai kahi haʻahaʻa o nā haʻalulu.

E hoʻemi i ka nui o ka kolamu ma ka meaʻai, pono ʻoe e hōʻemi i ka hoʻohana ʻana i nā huahana holoholona e waiwai nui i nā momona momona saturated. Pono hoʻi e hoʻonui i ka māhele o ka ʻai ʻana i nā meaʻai o nā mea kanu i nā momona momona polyunsaturated i loko o ka meaʻai.

Pono e hoʻemi i ka nui o ka paʻakai i hoʻopau ʻia i ka meaʻai.

Pono nā huahana i hoʻohana i ka hoʻomākaukau ʻana o ka meaʻai i ka nui o ka fiber.

ʻO nā huahana hoʻohana i ka wā e hahai ana i ka ʻai hypolipidemic:

• iʻa
• ʻai momona;
• kiniani
• soya
• nā ʻāpana a me nā bran;
• kaʻaila ʻōmaʻomaʻo, kahi antioxidant ikaika a me kahi inu e hoʻomaikaʻi ai i ka lipid metabolism.

Ke hōʻike ʻia nei e hoʻohui i ka kāleka maka i ka meaʻai. Kōkua kēia huahana e hoʻoneʻe i ke koko a pale i ka hoʻokumu ʻana o nā mākēkē o ke koko, a ua hōʻemi hoʻi kēia huahana i ka nui o ka kolamu ma muli o ke kuana mai o nā alliin i loko o kāna ʻano.

Hoʻolālā kūpono e pili ana i ka hypercholisterinemia

ʻO ka pinepine, ʻo kēia maʻi pathological he hoa o ka momona a me ka momona, ʻoi aku, hiki i ka maʻi ke hoʻoili.

ʻO ka pahuhopu nui o ka mālamaʻana i ka hōʻemi ʻana i nā lipids i ka plasma koko a hoʻoponopono i ka nui o ka hoʻoulu ʻana o ka cholesterol.

Eia kekahi, ʻo ka hana ʻelua o ka hoʻohana ʻana i nā ʻano hana ʻē aʻe o ka mālama ʻana, ka hoʻomaʻemaʻe ʻana i ka kaila kaila o nā poli o nā kolesterol a me ka hoʻokumu ʻana o ke kaila koko maʻamau.

I mua o kahi kikoʻī o nā lipids nui, e kuhikuhi ʻia e inu i nā mea inu i hoʻoilo ʻia mai nā huaʻaila o ka lehu kuahiwi. Pono e hoʻomākaukau i nā mea inu no ka ʻai ʻana me ka hoʻohana ʻana i nā mea momona. ʻO ka nui o ka inu i hoʻohanaʻia i kēlā me kēia lā e pono ai ma kahi o ka oi aku ma mua o 300 mauʻa.

Hiki iā ʻoe ke mākaukau ma ke ʻano he decoction e kau ana i nā aʻa o ka laikini kapa ʻole. No ka hana no kēia mea, ua hoʻohana ʻia he 10 mau kākela o ka hana maka. E ninini ʻia ka puna maka me ka wai i hoʻolapalapa ʻia ai ka wela i loko o ka ʻauʻau wai ma lalo o kahi uhi paʻa no nā minuke 40 mau minuke.

A kānana ʻia ka huahana i hoʻomākaukau ʻia a kāwele ʻia i ka pōpō. Noea ʻia e lawe i kahi decoction o 15 ml no kēlā me kēia lā 5 mau manawa. ʻO ke ala e mālama ai he 10 mau lā. I ka pau ʻana o ke papa, hana ʻia kahi hoʻomaha a, inā pono, ʻike hou ʻia.

Hiki iā ʻoe ke lawe i ka aila linseed o 20 kalama no ka mālama ʻana i ke kakahiaka ma kahi ʻōpū ʻole. ʻO 40 mau lōʻihi ka lōʻihi o ka mālama ʻana me kahi 20 o nā lā. ʻO ka lōʻihi me ka aila linseed ka lōʻihi. Akā he maikaʻi loa kēia mea hana a hana ma ke kaʻina kaʻina.

No ka hoʻonuiʻana i nā metabolism cholesterol, hiki iā ʻoe ke hoʻohana i ka turmeric ground root lōʻihi. Mai ka 1 a me 6 mauʻano o ka huahana e hoʻopau i kēlā me kēia lā.

Pono ka hana ʻana o ka hypercholesterolemia me nā ʻano koho ʻē aʻe ma hope o ke kūkākūkā ʻana me ke kauka hele ʻana a me ka hoʻokolohua komo me ke ana ʻana i ka pae o lipids i ka plasma koko a me ke ana ʻana i nā kaha o ka pākuʻi lipid.

Ke alakaʻi nei i ka mālama ʻana, e pono e mālama i nā hoʻokolohua liʻiliʻi ma ka manawa hoʻokahi i kēlā me kēia ʻeono mahina. Inā pono, ma hope o ka nānā ʻana, hiki i ke kauka ke kuhikuhi i kahi kaʻina hemodialysis.

ʻO nā mea āpau e pili ana i ka cholesterol i ho'ākāka ʻia i ka wikiō ma kēia ʻatikala.